Amol Akhade, Senior consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals, reshared his post on X, adding:
“Will Laura show OS benifit at 60 % maturity?
This is what AI thinks. Can any AI expert use current data and predict OS for Laura at 60 % maturity of data (current is 31 % mature).”
Quoting Amol Akhade‘s original post:
“Updated OS curves of Laura trial. Data yet to fully mature. 80 % Cross over. Do u think it will show os eventually?”
